An improved LC-MS/MS method for the detection of classic and low excretor glutaric acidemia type 1

[1]  D. Chace,et al.  Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[2]  J. Christodoulou,et al.  Glutaric aciduria type I: outcome following detection by newborn screening , 2008, Journal of Inherited Metabolic Disease.

[3]  Piero Rinaldo,et al.  Acylcarnitine profile analysis , 2008, Genetics in Medicine.

[4]  J. Zschocke,et al.  Decline of Acute Encephalopathic Crises in Children with Glutaryl-CoA Dehydrogenase Deficiency Identified by Newborn Screening in Germany , 2007, Pediatric Research.

[5]  S. Waisbren,et al.  Expanded Newborn Screening for Biochemical Disorders: The Effect of a False-Positive Result , 2006, Pediatrics.

[6]  G. Enns,et al.  Glutaryl-CoA dehydrogenase deficiency and newborn screening: retrospective analysis of a low excretor provides further evidence that some cases may be missed. , 2005, Molecular genetics and metabolism.

[7]  A. Ribes,et al.  Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency , 2004, Journal of Inherited Metabolic Disease.

[8]  J. Pitt,et al.  Pseudo-glutarylcarnitinaemia in medium-chain acyl-CoA dehydrogenase deficiency detected by tandem mass spectrometry newborn screening , 2004, Journal of Inherited Metabolic Disease.

[9]  E. Treacy,et al.  Profound neurological presentation resulting from homozygosity for a mild glutaryl-CoA dehydrogenase mutation with a minimal biochemical phenotype , 2003, Journal of Inherited Metabolic Disease.

[10]  D. Chace,et al.  Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. , 2003, Clinical chemistry.

[11]  E. Puffenberger,et al.  Type I glutaric aciduria, part 1: Natural history of 77 patients , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.

[12]  K. Strauss,et al.  Type I glutaric aciduria, part 2: A model of acute striatal necrosis , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.

[13]  M. Bennett,et al.  The changing face of newborn screening: diagnosis of inborn errors of metabolism by tandem mass spectrometry. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[14]  D. Millington,et al.  Glutaric acidemia, type I, missed by newborn screening in an infant with dystonia following promethazine administration. , 2001, Pediatrics.

[15]  M. Orozco,et al.  Glutaryl-CoA Dehydrogenase Deficiency in Spain: Evidence of Two Groups of Patients, Genetically, and Biochemically Distinct , 2000, Pediatric Research.

[16]  M. Bennett,et al.  Improved Stable Isotope Dilution-Gas Chromatography-Mass Spectrometry Method for Serum or Plasma Free 3-Hydroxy-Fatty Acids and Its Utility for the Study of Disorders of Mitochondrial Fatty Acid β-Oxidation , 2000 .

[17]  C E Hop,et al.  Integrating qualitative and quantitative liquid chromatography/tandem mass spectrometric analysis to support drug discovery. , 1999, Rapid communications in mass spectrometry : RCM.

[18]  D. Morton,et al.  Gene structure and mutations of glutaryl-coenzyme A dehydrogenase: impaired association of enzyme subunits that is due to an A421V substitution causes glutaric acidemia type I in the Amish. , 1996, American journal of human genetics.